Home / Wiki / P / Proteomics

Proteomics

Investment and Capital MarketsUpdated 16 Nov 2026

Proteomics is the large-scale study of proteins, the molecules that carry out most of the work in living cells. It seeks to identify which proteins a cell or tissue contains, in what amounts, how they are modified and how they interact. It builds on genomics, since genes hold the instructions for making proteins, but a gene sequence does not reveal how much of a protein is present or active at a given time. The main laboratory tool is mass spectrometry, joined by newer methods that measure thousands of proteins in a blood sample.

In markets, proteomics is followed as part of thematic investing in life sciences. Interest centres on makers of research instruments and reagents, diagnostics firms seeking protein markers of disease, and drug developers, some of which apply artificial intelligence to predict protein structures. Many such companies are early-stage, often backed by venture capital, and their revenues depend on research budgets and long clinical timelines.

Last updated 16 Nov 2026